Showing results (1741-1750 of 1,828) with videos related to

Sort By:
Pageof 183
The Clinical Respiratory Journal|January 5, 2025
Study Protocol of the Korean EGFR Registry: A Multicenter Prospective and Retrospective Cohort Study in Nonsmall Cell Lung Cancer Patients With EGFR MutationChang Dong Yeo, Dong Won Park, Seong Hoon Yoon, et al.
JCI Insight|June 11, 2026
Fatty acid amide hydrolase inhibition for treatment of amyotrophic lateral sclerosisDaisuke Ito, Madoka Iida, Yohei Iguchi, et al.
Science Advances|July 24, 2026
Van der Waals template-encoded soft epitaxy of tellurium enabled by atomic layer depositionChanghwan Kim, Hyeon Cho, Chuqiao Shi, et al.
The European Respiratory Journal|January 9, 2025
Inhibition of AXL ameliorates pulmonary fibrosis via attenuation of M2 macrophage polarisationDong Ha Kim, Kyungtaek Im, In-Jeoung Baek, et al.
Heart (British Cardiac Society)|April 10, 2015
Culprit or multivessel revascularisation in ST-elevation myocardial infarction with cardiogenic shockJin Sup Park, Kwang Soo Cha, Dae Sung Lee, et al.
Yonsei Medical Journal|October 9, 2015
Effects of Intracoronary Administration of Autologous Adipose Tissue-Derived Stem Cells on Acute Myocardial Infarction in a Porcine ModelHye Won Lee, Han Cheol Lee, Jong Ha Park, et al.
Biochemical and Biophysical Research Communications|August 1, 2016
The E3 ubiquitin ligase CHIP selectively regulates mutant epidermal growth factor receptor by ubiquitination and degradationChaeuk Chung, Geon Yoo, Tackhoon Kim, et al.
Cancer Communications (London, England)|June 6, 2018
Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II studyJung Hoon Kim, Sang-Cheol Lee, Sung Yong Oh, et al.
Cardiology Journal|January 19, 2016
The impact of transferring patients with ST-segment elevation myocardial infarction to percutaneous coronary intervention-capable hospitals on clinical outcomesBo Won Kim, Kwang Soo Cha, Min Joung Park, et al.
Oncology Letters|July 12, 2012
Phase II study of palliative S-1 in combination with cisplatin as second-line chemotherapy for gemcitabine-refractory pancreatic cancer patientsHyun Jung Kim, Jina Yun, Han Jo Kim, et al.
Pageof 183